Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
about
Shotgun lipidomics identifies a paired rule for the presence of isomeric ether phospholipid molecular speciesHuman and great ape red blood cells differ in plasmalogen levels and compositionMetabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomicsAlzheimer's disease as homeostatic responses to age-related myelin breakdownShotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodelingNeurolipidomics: challenges and developmentsPeroxisomes in brain development and functionObesity and psychotic disorders: uncovering common mechanisms through metabolomicsFingolimod for the treatment of neurological diseases-state of play and future perspectivesDifferential Lipid Profiles of Normal Human Brain Matter and Gliomas by Positive and Negative Mode Desorption Electrospray Ionization – Mass Spectrometry ImagingShotgun lipidomics: multidimensional MS analysis of cellular lipidomesPotential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomicsHippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometryDefects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellumPlasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signalingTopogenesis and homeostasis of fatty acyl-CoA reductase 1Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS.A study of phospholipids by ion mobility TOFMSDirect profiling of tissue lipids by MALDI-TOFMSCirculating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patientsQuantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.Shotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applicationsDeficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.Metal and complementary molecular bioimaging in Alzheimer's disease.Peroxisomal alterations in Alzheimer's diseaseBrain lipidomes of subcortical ischemic vascular dementia and mixed dementiaMulti-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study.Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.Dual-mode phospholipid regulation of human inward rectifying potassium channelsEfficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled TrialPlasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.Metabolomic changes in autopsy-confirmed Alzheimer's diseaseAcetate supplementation attenuates lipopolysaccharide-induced neuroinflammationLipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria.Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.
P2860
Q21144365-4A4E695C-2E96-4DD9-B841-58F53869068DQ21245699-03CB9DB2-05FC-4AB1-8642-F060C9DEC457Q21560953-89F21AAB-1F42-4B7D-BE48-252879239C64Q22251261-B46B3129-D2EF-461D-8F29-DDA9FEF253EAQ24645695-EC612877-5741-4DA5-92DF-1AA3A796AFBCQ24676920-30768661-6E26-4EF7-8FE4-E43B66FD1D29Q26774697-15317128-10DE-421D-9110-1145BB32329EQ27011617-8F94942A-0CAE-4B38-8788-B46D743367A2Q27026175-09C08605-5FB1-4CE3-914B-3104E8072871Q27321766-BAAAD9A2-266F-42C6-AE2D-EF8022BDA1C9Q28250539-F745B123-D9D8-4000-8DC3-67378B083CB3Q28256439-9A8BC605-0907-4473-8F98-0E8DF63DB65FQ28391606-601F172D-77AB-406B-8322-34FC6AAF4384Q28512474-1DC4F75B-9CF3-4C80-9A7A-DA1D647F3CE1Q28537867-A451BA72-4D1D-43E5-BA85-F9D7949A1A94Q29871499-DE5A91B7-FDEA-4E6F-BE6B-FE66E7BE417FQ30417407-36E7AC61-8165-4391-B670-CF0A70CBE20CQ30451918-77FA13C8-FE68-4145-BFF1-D451D880913AQ33258634-5108D815-EAD9-4177-8E85-939F2F307264Q33360194-19FC847B-79A7-4560-9FF5-F861921C6845Q33394497-7BE74C20-B2EE-4AF4-BEB8-B4E8EE4B6006Q33563175-B745C0BE-E20F-4B39-9581-0AD64CF7FA04Q33634200-8AFE381C-08C0-4B46-A761-39FB3D11FA5BQ33652547-C130579E-0DE9-4899-AA9A-6A5BD80BEE53Q33691534-D046253A-34B9-40AC-BE49-85E25DA47A02Q33770447-F8264F20-924E-419F-944F-6E8CB7E342F8Q33901773-E634EBCC-735B-4952-B01E-40E7F35465CDQ33905478-99E56148-C79B-45BE-9241-0E76B36C92B4Q33906496-48EA9C55-35DA-4457-8BE3-EC752D6AFF0FQ33915435-0CE0F57A-31C4-4B7D-87AF-C7F9C9D895BBQ33986680-7BB94EF6-67AC-4CF2-AD0B-3DCEAB6E1382Q34421898-2635A706-32A5-4CB8-B079-E873AF86CB01Q34535871-C798D5C7-454F-436F-88FE-15A81AE59C56Q34552659-A323FA72-25BB-4D05-B3D3-940221C3592FQ34626206-4D7F3DAE-0309-463E-B17E-E006EC94AAB6Q34700264-9D11830C-0751-4D68-8875-BCB6B8843429Q34762159-65EDF571-7FFA-4A7F-B905-1A2512E98C82Q35013455-378FDD9F-804A-4084-A953-6B77B42B84DFQ35116978-F2BA1670-2D91-4384-A1A9-193C04868C94Q35218379-1A4596FB-A671-43C3-A105-43CB287D1596
P2860
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@ast
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@en
type
label
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@ast
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@en
prefLabel
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@ast
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@en
P2860
P1476
Plasmalogen deficiency in earl ...... ionization mass spectrometry.
@en
P2093
P2860
P304
P356
10.1046/J.1471-4159.2001.00332.X
P407
P577
2001-05-01T00:00:00Z